Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,652.7
-16.8 (-0.63%)

 

  • STI Straits Times Index
    2,652.7
    -16.8 (-0.63%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,591.8
    8.6 (0.54%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,727.4
    -482.8 (-1.84%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,383.3
    -67.3 (-1.95%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,290.8
    -238.5 (-1.06%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,031.3
    -21.5 (-0.43%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,451.9M
  • Value: 1,077.1M
  • Rise: 168
  • Fall: 215
  • Unch: 425

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
QT Vascular0.009+0.004
AsiaMedic0.031+0.011
Adventus0.025+0.005
Singapore-eDev0.130-0.003
Anchor Resources0.007+0.001
Medtecs Intl0.870+0.050
Clearbridge0.185+0.013
Biolidics0.410+0.100
3Cnergy0.019+0.002
Thomson Medical0.060+0.001

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

UG Healthcare UG HEALTHCARE CORPORATION LTD
Quotes 10 Minutes Delayed. Updated at 09 Jul 2020 17:14
Last (SGD): 1.970 Change: +0.170 High: 2.010 Remarks: -
Change (%): +9.44 Low: 1.850
Open 1.880 Yesterday's Close 1.800
Buy Price 1.970 Sell Price 1.980
Buy Volume ('000) 72.0 Sell Volume ('000) 73.0
Cumulative Volume ('000) 15,679.0 Cumulative Value 30,501,518
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.01278 Trailing EPS (SGD) e 0.01037 NAV (SGD) b 0.2166
PE a 154.147 Trailing PE f 189.923 Price / NAV b 9.0951
Dividend (SGD) d 0.002553 Cash In Hand (SGD) g 0.0167 Issued & Paid-up Shares c 196,093,000
Dividend Yield (%) d 0.130 Price / Cash In Hand g 117.964 Treasury Shares h -
Beta - 75 Daysi 0.504 R-Squared - 75 Days(%)i 0.09 Market Cap (M) 386.303
Beta - 500 Daysi 0.127 R-Squared - 500 Days (%)i 0.08 Enterprise Value (M) 423.201
Piotroski F Score 3 Exchange Code 41A Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 104.1573 6-Month VWAP 0.574 Free Float (%) -
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 17 Feb 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference UG Healthcare SGX 386.303 154.147 189.923 9.0951 0.130
Industry Medical & Biotechnology SGX 937.449 20.731 22.772 1.3171 2.046
Medical Specialties SGX 3,261.095 166.866 93.583 15.2127 0.325
Local Peer Top Glove SGX 18,535.064 152.078 86.542 16.8917 0.340
Local Peer Medtecs Intl SGX 477.988 305.263 305.423 5.5805 -
Local Peer Biolidics SGX 106.747 - - 9.8086 -
Local Peer Yunnan Energy SGX 43.794 - - 0.9014 -
Local Peer Annica SGX 16.675 - - 3.3333 -
Global Peer ABBOTT LABORATORIES NYSE 164,573.804 44.892 46.503 5.4462 1.414
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 151,096.404 40.881 41.182 5.2907 0.201
Global Peer DANAHER CORP NYSE 130,120.460 52.282 47.541 4.4175 0.363
Global Peer MEDTRONIC PLC NYSE 121,803.453 25.434 25.434 2.4007 2.378
Global Peer BECTON DICKINSON & CO NYSE 72,958.990 67.430 80.175 3.4827 1.149
Global Peer INTUITIVE SURGICAL INC NASDAQ 67,156.808 48.689 48.443 7.8946 -
Global Peer STRYKER CORP NYSE 66,678.153 32.011 30.812 5.0841 1.199
Global Peer BOSTON SCIENTIFIC CORP NYSE 49,548.356 10.542 11.558 3.5894 -
Global Peer BAXTER INTERNATIONAL INC NYSE 43,368.092 43.325 42.476 5.6330 0.992
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 43,029.033 32.943 32.943 3.0431 1.907
Other Global Peers EDWARDS LIFESCIENCES CORP (NYSE), DEXCOM INC (NASDAQ), IDEXX LABORATORIES INC (NASDAQ), ALCON AG (NYSE), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), TOPGLOV (Bursa), INSULET CORPORATION (NASDAQ), HARTA (Bursa), FISHER & PAYKEL HEALTHCARE CORP (ASX), STERIS PLC (NYSE), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), WATERS CORP (NYSE), WEIGAO GROUP (HKEx), PERKINELMER INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), QUIDEL CORP (NASDAQ), QIAGEN NV (NYSE), MICROPORT (HKEx), DENTSPLY SIRONA INC (NASDAQ), COCHLEAR LTD (ASX), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), TANDEM DIABETES CARE INC (NASDAQ), BRUKER CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), KANGJI MEDICAL (HKEx), GLOBUS MED INC (NYSE), HAEMONETICS CORP (NYSE), SUPERMX (Bursa), VENUS MEDTECH-B (HKEx), NEOGEN CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), AK MEDICAL (HKEx), NEVRO CORP (NYSE), WRIGHT MEDICAL GROUP NV (NASDAQ), ICU MEDICAL INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), IRHYTHM TECHNOLOGIES INC (NASDAQ), PEIJIA-B (HKEx), NUVASIVE INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), INARI MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), EBOS GROUP (ASX), CONMED CORP (NYSE), ATRICURE INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), CAREDX INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), KDL MEDICAL (HKEx), SILK ROAD MEDICAL INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), LIFETECH SCI (HKEx), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), GENMARK DIAGNOSTICS INC (NASDAQ), ATRION CORP (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), VAPOTHERM INC (NYSE), CERUS CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ZYNEX INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), INMODE LTD (NASDAQ), CIRC (HKEx), HESKA CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), INOGEN INC (NASDAQ), VERICEL CORP (NASDAQ), NATUS MEDICAL INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CRYOLIFE INC (NYSE), BIOLIFE SOLUTIONS INC (NASDAQ), QUOTIENT LTD (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), SI BONE INC (NASDAQ), AXOGEN INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), CORMEDIX INC (NYSE American), ESTABLISHMENT LABS HLDGS INC (NASDAQ), YESTAR HEALTH (HKEx), MCP INCOME OPPORTUNITIES TRUST (ASX), PW MEDTECH (HKEx), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), VIEWRAY INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), GOLDEN MEDITECH (HKEx), MEDICAL DEVELOPMENT INTL (ASX), STEREOTAXIS INC (NYSE American), PROFOUND MED CORP (NASDAQ), VINCENT MED (HKEx), IRADIMED CORP (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), ALPHA PRO TECH (NYSE American), PULSE BIOSCIENCES INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), MISONIX INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), RETRACTABLE TECHNOLOGIES INC (NYSE American), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), INVACARE CORP (NYSE), BIOSIG TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), SIENTRA INC (NASDAQ), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), DERMTECH INC (NASDAQ), SOLITON INC (NASDAQ), MODERN DENTAL (HKEx), APYX MEDICAL CORPORATION (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), FONAR CORP (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROMED INC (NYSE American), BELLEROPHON THERAPEUTICS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), CELSION CORPORATION (NASDAQ), INTRICOM CORP (NASDAQ), BIOMERICA INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), PAVMED INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), CHEMBIO DIAGNOSTICS INC (NASDAQ), CYCLOPHARM LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), RESAPP HEALTH LIMITED (ASX), MILESTONE SCIENTIFIC INC (NYSE American), DAXOR CORP (NYSE American), SOMNOMED LIMITED (ASX), ENLIVEX THERAPEUTICS LTD (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), YUNNAN ENERGY (HKEx), NEPHROS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CONFORMIS INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), SDI LTD (ASX), LKL (Bursa), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), COMPUMEDICS (ASX), CLEARPOINT NEURO INC (NASDAQ), DIMERIX LTD (ASX), TITAN MEDICAL INC (NASDAQ), IMPEDIMED LIMITED (ASX), RESONANCE HEALTH LTD (ASX), SENSUS HEALTHCARE INC (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), ZOSANO PHARMA CORP (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), KELFRED (HKEx), RESPIRI LTD (ASX), ONCOCYTE CORP (NYSE American), IMMUCELL CORP (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), NEOVASC INC (NASDAQ), NEURONETICS INC (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), MICRO-X LTD (ASX), SINTX TECHNOLOGIES INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), ELECTROCORE INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), DELCATH SYSTEMS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), IRIDEX CORP (NASDAQ), USCOM LTD (ASX), METALICITY LIMITED (ASX), NEUROTROPE INC (NASDAQ), LBT INNOVATIONS LTD (ASX), DARIOHEALTH CORP (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), CHF SOLUTIONS INC (NASDAQ), BIOLASE INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), LIFE HEALTHCARE (HKEx), AKERS BIOSCIENCES INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), CHECK-CAP LTD (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), AVINGER INC (NASDAQ), CARDIEX LTD (ASX), MYOS RENS TECHNOLOGY INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), OPTISCAN IMAGING (ASX), CYANOTECH CORP (NASDAQ), DIGIRAD CORP (NASDAQ), DYNATRONICS CORP (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), ADHERIUM LIMITED (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), ANALYTICA (ASX), CANCER GENETICS INC (NASDAQ), HUAKANG BIOMED (HKEx), NEUROMETRIX INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), ENDOLOGIX INC (NASDAQ), STHAI (SET), DORSAVI LTD (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.630
+47.01 %
10 Days -+0.910
+85.85 %
20 Days -+1.215
+160.93 %
Medium Term Return 3 Months -+1.773
+900.00 %
6 Months -+1.820
+1213.33 %
1 Year 0.003+1.796
+1033.91 %
Long Term Return 2 Years 0.005+1.740
+758.70 %
3 Years 0.005+1.720
+690.00 %
5 Years 0.011+1.685
+595.09 %
Annualised Return Annualised --
+47.37 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.131 - 2.010 Change From 1 Year Low +1.839 % Change From 1 Year Low (%) +1403.82
Change From 1 Year High -0.040 % Change From 1 Year High (%) -1.99
2 Years Range 0.131 - 2.010 Change From 2 Years Low +1.839 % Change From 2 Years Low (%) +1403.82
Change From 2 Years High -0.040 % Change From 2 Years High (%) -1.99
5 Years Range 0.131 - 2.010 Change From 5 Years Low +1.839 % Change From 5 Years Low (%) +1403.82
Change From 5 Years High -0.040 % Change From 5 Years High (%) -1.99
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

UG Healthcare Corporation Limited manufactures and distributes natural latex and nitrile examination gloves. It markets its natural latex and nitrile examination gloves under the Unigloves brand name, as well as under third party labels. The company also distributes ancillary products, such as surgical, vinyl, and cleanroom gloves, as well as face masks and other medical disposables. Its gloves are used in healthcare, food and beverage, and automotive industries. The company markets its products in approximately 50 countries, including Germany, Nigeria, the People's Republic of China, the United States, the United Kingdom, France, Italy, Austria, Switzerland, the Netherlands, Japan, South Korea, Canada, and Brazil. UG Healthcare Corporation Limited was founded in 1989 and is based in Seremban, Malaysia.

IPO Performance

Listing Date 08 Dec 2014 Full Subscription Rate (x) 11.51
No of Placement Shares (M) 27.00 No of Public Offer Shares (M) 1.80 Public Offer Subscription Rate (x) 169.08
IPO Price (SGD) 0.215 First Day Close (SGD) 0.250 First Week Close (SGD) 0.230
Current vs IPO Price (%) +816.28 First Day Gain (%) +16.28 First Week Gain (%) +6.98

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Jun 2019 Part 1(3.87 MB)
Annual Report 2018 Jun 2018 Part 1(3.37 MB)
Annual Report 2017 Jun 2017 Part 1(1.68 MB)
Part 2(0.17 MB)
Annual Report 2016 Jun 2016 Part 1(3.32 MB)
Annual Report 2015 Jun 2015 Part 1(1.19 MB)
IPO Prospectus
IPO Prospectus 2014 Dec 2014 Part 1(2.18 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
09 Jul 2020 1.880 2.010 1.850 1.970 15,679,000 1.9454
08 Jul 2020 1.600 1.800 1.560 1.800 12,981,600 1.6865
07 Jul 2020 1.550 1.610 1.450 1.560 13,422,300 1.5418
06 Jul 2020 1.340 1.530 1.340 1.500 10,940,800 1.4058
03 Jul 2020 1.360 1.380 1.300 1.330 7,500,800 1.3376
02 Jul 2020 1.320 1.360 1.290 1.340 9,594,100 1.3361
01 Jul 2020 1.190 1.290 1.190 1.290 11,639,200 1.2564
30 Jun 2020 1.120 1.200 1.110 1.180 11,940,600 1.1604
29 Jun 2020 1.080 1.140 1.060 1.110 11,837,600 1.1073
26 Jun 2020 1.110 1.120 1.050 1.080 10,495,200 1.0862
25 Jun 2020 1.000 1.070 0.995 1.060 7,878,300 1.0378
24 Jun 2020 0.990 1.080 0.955 1.000 27,978,600 1.0205
23 Jun 2020 0.855 0.995 0.845 0.980 58,622,800 0.9165
22 Jun 2020 0.790 0.810 0.780 0.785 4,140,400 0.7926
19 Jun 2020 0.810 0.815 0.790 0.790 5,266,800 0.8015
18 Jun 2020 0.800 0.830 0.795 0.805 7,670,600 0.8128
17 Jun 2020 0.810 0.820 0.790 0.800 4,770,900 0.8052
16 Jun 2020 0.820 0.830 0.795 0.810 5,734,500 0.8115
15 Jun 2020 0.815 0.850 0.785 0.790 18,691,200 0.8152
12 Jun 2020 0.725 0.815 0.710 0.805 15,650,800 0.7787
11 Jun 2020 0.800 0.830 0.725 0.755 18,446,600 0.7854
10 Jun 2020 0.720 0.820 0.710 0.815 24,468,200 0.7891
Summary
Current 2 Weeks
(26 Jun 2020 to 09 Jul 2020)
1.110 2.010 1.050 1.970 116,031,200 -
Previous 2 Weeks
(12 Jun 2020 to 25 Jun 2020)
0.725 2.010 0.710 1.060 156,404,900 -
4 Weeks from
(14 May 2020 to 11 Jun 2020)
0.355 2.010 0.340 0.755 293,649,400 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.